• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺式阿曲库铵在老年外科患者中的药效学和药代动力学

Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients.

作者信息

Ornstein E, Lien C A, Matteo R S, Ostapkovich N D, Diaz J, Wolf K B

机构信息

Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York 10032, USA.

出版信息

Anesthesiology. 1996 Mar;84(3):520-5. doi: 10.1097/00000542-199603000-00005.

DOI:10.1097/00000542-199603000-00005
PMID:8659778
Abstract

BACKGROUND

Cisatracurium, one of ten stereoisomers that comprise atracurium, is more potent than atracurium and has less propensity to release histamine. This study compares the pharmacokinetics and pharmacodynamics of cisatracurium in elderly and young patients.

METHODS

Twelve elderly (aged 65-82 yr) and 12 younger patients (aged 30-49 yr) were anesthetized with nitrous oxide, fentanyl, and isoflurane (0.7%, end-tidal). The mechanomyographic response to train-of-four stimulation was assessed every 15 s after the administration of cisatracurium (0.1 mg/kg). Arterial samples were obtained over 6 h. Plasma cisatracurium concentration versus time data were fit to compartmental models. Pharmacokinetic parameters were determined assuming that elimination occurred from the central compartment only. This provides accurate clearance and half-life estimates but underestimates V(ss) (reported herein as V(ss). The pharmacodynamic response was described by the neuromuscular blocking profile.

RESULTS

Onset to 90% paralysis (mean +/- SD) was delayed in the elderly (3.4 +/- 1.0 vs. 2.5 +/- 0.6 min). Recovery profiles were the same for both groups. Elimination half-life was minimally prolonged in the elderly (25.5 +/- 3.7 vs. 21.5 +/- 2.4 min). The Vss was larger in the elderly (126 +/- 16 vs. 108 +/- 13 ml/kg), although the clearances were the same for the two groups (5.0 +/- 0.9 vs. 4.6 +/- 0.8 ml.kg(-1).min(-1).

CONCLUSIONS

There are minor differences in the pharmacokinetics of cisatracurium between elderly and young patients. These differences are not associated with changes in recovery profile after a single bolus dose, although the mean time to onset was approximately 1 min longer in elderly patients.

摘要

背景

顺式阿曲库铵是组成阿曲库铵的十种立体异构体之一,其效力比阿曲库铵更强,且释放组胺的倾向较小。本研究比较了顺式阿曲库铵在老年和年轻患者中的药代动力学和药效学。

方法

12名老年患者(年龄65 - 82岁)和12名年轻患者(年龄30 - 49岁)接受氧化亚氮、芬太尼和异氟烷(呼气末浓度0.7%)麻醉。给予顺式阿曲库铵(0.1mg/kg)后每15秒评估一次对四个成串刺激的肌机械反应。在6小时内采集动脉血样。血浆顺式阿曲库铵浓度与时间数据拟合房室模型。假设仅从中枢室消除来确定药代动力学参数。这可提供准确的清除率和半衰期估计,但会低估稳态分布容积(本文报告为V(ss))。药效学反应通过神经肌肉阻滞曲线描述。

结果

老年患者达到90%麻痹的起效时间(平均值±标准差)延迟(3.4±1.0分钟 vs. 2.5±0.6分钟)。两组的恢复曲线相同。老年患者的消除半衰期略有延长(25.5±3.7分钟 vs. 21.5±2.4分钟)。老年患者的稳态分布容积更大(126±16 vs. 108±13ml/kg),尽管两组的清除率相同(5.0±0.9 vs. 4.6±0.8ml·kg⁻¹·min⁻¹)。

结论

老年和年轻患者之间顺式阿曲库铵的药代动力学存在微小差异。这些差异与单次推注剂量后的恢复曲线变化无关,尽管老年患者的平均起效时间约长1分钟。

相似文献

1
Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients.顺式阿曲库铵在老年外科患者中的药效学和药代动力学
Anesthesiology. 1996 Mar;84(3):520-5. doi: 10.1097/00000542-199603000-00005.
2
Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients.顺式阿曲库铵在青年和老年成年患者中的药代动力学和药效学
Anesthesiology. 1996 May;84(5):1083-91. doi: 10.1097/00000542-199605000-00010.
3
A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.在健康患者中,将阿曲库铵的1R-顺式1'R-顺式异构体顺阿曲库铵的输注药代动力学和药效学与苯磺阿曲库铵进行比较。
Anaesthesia. 1997 Sep;52(9):833-41. doi: 10.1111/j.1365-2044.1997.195-az0331.x.
4
Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation.顺式阿曲库铵在终末期肝病肝移植患者中的药代动力学和药效学
Br J Anaesth. 1996 May;76(5):624-8. doi: 10.1093/bja/76.5.624.
5
Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Anesthesiology. 1996 Feb;84(2):300-8. doi: 10.1097/00000542-199602000-00007.
6
Clinical pharmacokinetics of cisatracurium besilate.苯磺顺阿曲库铵的临床药代动力学
Clin Pharmacokinet. 1999 Jan;36(1):27-40. doi: 10.2165/00003088-199936010-00003.
7
Newer neuromuscular blocking agents: how do they compare with established agents?新型神经肌肉阻滞剂:与现有药物相比如何?
Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003.
8
Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.顺式阿曲库铵(51W89)、阿曲库铵及其五种异构体在猫体内的比较药理学
Anesthesiology. 1996 Jul;85(1):169-77. doi: 10.1097/00000542-199607000-00023.
9
Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient.顺式阿曲库铵在麻醉患者中三种不同剂量水平的浓度-效应关系。
Anesthesiology. 2001 Aug;95(2):314-23. doi: 10.1097/00000542-200108000-00010.
10
[The clinical pharmacology of cisatracurium].[顺式阿曲库铵的临床药理学]
Anaesthesist. 1997 Jun;46(6):481-5. doi: 10.1007/s001010050427.

引用本文的文献

1
Comparison of onset time, duration of action, and intubating conditions after cisatracurium 0.15 mg/kg in young and elderly patients.0.15mg/kg 顺式阿曲库铵在年轻和老年患者中起效时间、作用持续时间和插管条件的比较。
BMC Anesthesiol. 2022 Nov 7;22(1):339. doi: 10.1186/s12871-022-01881-5.
2
The median effective dose (ED50) of cis-Atracurium for laryngeal mask airway insertion during general Anaesthesia for patients undergoing urinary surgery.全麻下经尿道手术患者行喉罩置入时顺式阿曲库铵的半数有效剂量(ED50)。
BMC Anesthesiol. 2020 Mar 19;20(1):68. doi: 10.1186/s12871-020-00982-3.
3
Effective doses of cisatracurium in the adult and the elderly.
顺式阿曲库铵在成人和老年人中的有效剂量。
Korean J Anesthesiol. 2016 Oct;69(5):453-459. doi: 10.4097/kjae.2016.69.5.453. Epub 2016 Sep 8.
4
Neuromuscular blockade in the elderly patient.老年患者的神经肌肉阻滞
J Pain Res. 2016 Jun 17;9:437-44. doi: 10.2147/JPR.S85183. eCollection 2016.
5
The comparison of predictive performance in bispectral index prediction during target effect-site controlled infusion of propofol using different blood effect-site equilibration rate constants in the same pharmacokinetic model.同一药代动力学模型中不同血药-效应室平衡速率常数用于目标效应室靶控输注丙泊酚时脑电双频指数预测性能的比较。
Korean J Anesthesiol. 2013 Oct;65(4):299-305. doi: 10.4097/kjae.2013.65.4.299. Epub 2013 Oct 24.
6
The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis.危重症脓毒症患者顺式阿曲库铵的药代动力学和药效学。
Br J Clin Pharmacol. 2012 May;73(5):741-9. doi: 10.1111/j.1365-2125.2011.04149.x.
7
Anaesthesia and postoperative analgesia in older patients with chronic obstructive pulmonary disease: special considerations.老年慢性阻塞性肺疾病患者的麻醉与术后镇痛:特殊考量
Drugs Aging. 2003;20(5):347-60. doi: 10.2165/00002512-200320050-00004.
8
Selecting neuromuscular-blocking drugs for elderly patients.为老年患者选择神经肌肉阻滞剂
Drugs Aging. 2003;20(2):125-40. doi: 10.2165/00002512-200320020-00004.
9
Newer neuromuscular blocking agents: how do they compare with established agents?新型神经肌肉阻滞剂:与现有药物相比如何?
Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003.
10
Clinical pharmacokinetics of the newer neuromuscular blocking drugs.新型神经肌肉阻滞药物的临床药代动力学
Clin Pharmacokinet. 1999 Mar;36(3):169-89. doi: 10.2165/00003088-199936030-00001.